Biorasi Completes Rare Nephrology Trial During COVID-19
Biorasi has completed subject visits under Part A in a rare disease nephropathy study during the peak of the COVID-19 outbreak.
30
06, 2020
24
06, 2020
Biorasi Begins Second COVID-19 Clinical Trial of 2020
Biorasi is proud to announce the start of a second COVID-19 clinical trial for 2020. The trial will be executed in Russia and Ukraine and will focus on the efficacy of prophylaxis medication for maintaining the health and safety of healthcare personnel treating patients with the coronavirus.
6
05, 2020
Biorasi Starts First COVID-19 Clinical Trial in May 2020
Biorasi is proud to announce the initiation of the company’s first COVID-19 clinical trial in May 2020. The U.S.-based trial will focus on the treatment for lung injuries caused by the COVID-19 virus.
24
04, 2020
Biorasi’s Kurt Gehlsen Appointed to COVID-19 Rapid Response Panel
Dr. Kurt Gehlsen, Chief Scientific Officer and Vice President of Medical and Scientific Affairs, has been appointed to the COVID-19 Rapid Response Funding panel at Science Foundation Ireland (SFI).
5
03, 2020
Biorasi Recognizes Rare Disease Day with Company-Wide Event and Fundraiser
In observance of Rare Disease Day 2020, Biorasi, LLC held a company-wide event and fundraiser to raise awareness for Angelman Syndrome. The company contributed over $4,000 to the Foundation for Angelman Syndrome Therapeutics. Read more about the highlights of this event >>
20
02, 2020
Biorasi Welcomes Chris O’Brien as Chief Executive Officer
Biorasi, LLC and its Board of Directors are proud to announce the appointment of Chris O’Brien to the position of Chief Executive Officer (CEO). O’Brien will assume day-to-day leadership of Company operations, working closely with the Biorasi leadership team to deliver cutting-edge solutions for clinical research project management.
30
01, 2019
Press Release: Leading Global CRO Hires Dr. Kurt R. Gehlsen as VP, Chief Scientific Officer
Celebrated Industry Veteran to Lead Scientific, Medical, and Regulatory Affairs at Biorasi
Miami, FL, Jan 29, […]
9
01, 2019
Introducing Biorasi’s Center of Excellence: Dermatology
Biorasi has a solid track record of experience in dermatology, and our goal for this year […]
12
12, 2018
11
12, 2018
Press Release: Biorasi Partners with RLH Equity to Spur Expansion and Growth
Florida-Based CRO seeks to expand offerings, global footprint, and headcount after successful investment transaction.
Biorasi, a leading […]
9
08, 2018
Biorasi Joins Nova Southeastern University to Spur Healthcare Job Growth in South Florida
Leading Florida-based Contract Research Organization Partners With University to Train Tomorrow’s Medical Research Professionals
Miami, FL, Aug. […]
5
07, 2018
The Future is Here for Clinical Trials, and It Introduces New Risks
Mobile phone apps and wearable devices have a lot of potential to improve clinical studies. However, […]
